• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌(II)膦/二亚胺/吡啶甲酸盐配合物:作为抗结核药物的无机化合物。

Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.

机构信息

Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, CEP 14801-902, Araraquara, SP, Brazil.

出版信息

Eur J Med Chem. 2011 Oct;46(10):5099-107. doi: 10.1016/j.ejmech.2011.08.023. Epub 2011 Aug 23.

DOI:10.1016/j.ejmech.2011.08.023
PMID:21875763
Abstract

This paper describes the synthesis and characterization of four new ruthenium complexes containing 1,4 bis(diphenylphosphino)butane (dppb), 2-pyridinecarboxylic acid anion (pic) and the diimines [(2,2'-bipyridine (bipy), 4,4'-dimethyl-2,2'-bipyridine (Me-bipy), 4,4'-dichloro-2,2'-bipyridine (Cl-bipy) and 1,10-phenanthroline (phen) as ligands, with formulae [Ru(pic)(dppb)(bipy)]PF(6) (SCAR01), [Ru(pic)(dppb)(Me-bipy)]PF(6) (SCAR02), [Ru(pic)(dppb)(Cl-bipy)]PF(6) (SCAR03) and [Ru(pic)(dppb)(phen)]PF(6) (SCAR04). Additionally, the in vitro anti-Mycobacterium tuberculosis (MTB) activity, cytotoxicity and activity against in vitro infection of these complexes and two more complexes, cis-[Ru(pic)(dppe)(2)]PF(6) (SCAR05) and cis-[RuCl(2)(dppb)(bipy)] (SCAR06), and their free ligands are described and discussed. All compounds showed excellent MIC against MTB, low cytotoxicity and a selectivity index higher than 10. Also, all compounds showed significant intracellular inhibition and the compound SCAR05 showed a better activity than rifampin and SQ109. This is the first report of activity against in vitro infection of ruthenium compounds.

摘要

本文描述了四种新的钌配合物的合成与表征,这些配合物含有 1,4-双(二苯基膦)丁烷(dppb)、2-吡啶甲酸阴离子(pic)和二亚胺[(2,2'-联吡啶(bipy)、4,4'-二甲基-2,2'-联吡啶(Me-bipy)、4,4'-二氯-2,2'-联吡啶(Cl-bipy)和 1,10-菲咯啉(phen)作为配体,其化学式为[Ru(pic)(dppb)(bipy)]PF(6)(SCAR01)、[Ru(pic)(dppb)(Me-bipy)]PF(6)(SCAR02)、[Ru(pic)(dppb)(Cl-bipy)]PF(6)(SCAR03)和[Ru(pic)(dppb)(phen)]PF(6)(SCAR04)。此外,还描述和讨论了这些配合物以及另外两种配合物 cis-[Ru(pic)(dppe)(2)]PF(6)(SCAR05)和 cis-[RuCl(2)(dppb)(bipy)](SCAR06)及其游离配体的体外抗结核分枝杆菌(MTB)活性、细胞毒性和体外感染活性。所有化合物对 MTB 的 MIC 均表现出优异的抑制活性,细胞毒性低,选择性指数高于 10。此外,所有化合物均表现出显著的细胞内抑制作用,化合物 SCAR05 的活性优于利福平(rifampin)和 SQ109。这是首例关于钌化合物对体外感染活性的报道。

相似文献

1
Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.钌(II)膦/二亚胺/吡啶甲酸盐配合物:作为抗结核药物的无机化合物。
Eur J Med Chem. 2011 Oct;46(10):5099-107. doi: 10.1016/j.ejmech.2011.08.023. Epub 2011 Aug 23.
2
Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents.钌(II)膦酸/皮考啉酸盐配合物作为抗分枝杆菌药物。
Eur J Med Chem. 2010 Feb;45(2):598-601. doi: 10.1016/j.ejmech.2009.10.049. Epub 2009 Nov 6.
3
Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.含“SpymMe2”配体(SpymMe2 = 4,6 - 二甲基 - 2 - 巯基嘧啶)的钌(II)膦/二亚胺配合物的合成、表征、X射线结构以及体外抗分枝杆菌和抗肿瘤活性
J Inorg Biochem. 2008 Sep;102(9):1783-9. doi: 10.1016/j.jinorgbio.2008.05.009. Epub 2008 May 29.
4
Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement.将硝基亚氨基硫代半卡巴腙与钌(II)配位作为提高抗锥虫活性的策略。
Eur J Med Chem. 2010 Jul;45(7):2847-53. doi: 10.1016/j.ejmech.2010.03.005. Epub 2010 Mar 11.
5
Antiparasitic activities of novel ruthenium/lapachol complexes.新型钌/拉帕醇配合物的抗寄生虫活性
J Inorg Biochem. 2014 Jul;136:33-9. doi: 10.1016/j.jinorgbio.2014.03.009. Epub 2014 Mar 27.
6
In vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosis.钌(II)膦/二亚胺/吡啶甲酸盐配合物(SCAR)对结核分枝杆菌的体外和体内活性。
PLoS One. 2013 May 28;8(5):e64242. doi: 10.1371/journal.pone.0064242. Print 2013.
7
Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).顺式-[RuCl(BzCN)(N-N)(P-P)]PF6配合物:合成与体外抗肿瘤活性:(BzCN = 苄腈;N-N = 2,2'-联吡啶;1,10-菲咯啉;P-P = 1,4-双(二苯基膦基)丁烷、1,2-双(二苯基膦基)乙烷或1,1'-(二苯基膦基)二茂铁)。
J Inorg Biochem. 2015 Aug;149:91-101. doi: 10.1016/j.jinorgbio.2015.03.011. Epub 2015 Mar 31.
8
In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].一种新型羰基钌化合物ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb = 1,4-双(二苯基膦基)丁烷,bipy = 2,2'-联吡啶]的体外和体内抗肿瘤活性
J Inorg Biochem. 2016 Nov;164:42-48. doi: 10.1016/j.jinorgbio.2016.08.010. Epub 2016 Aug 25.
9
Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.钌(II)/克霉唑/二苯基膦/联吡啶配合物:与DNA、牛血清白蛋白的相互作用以及对肿瘤细胞系和结核分枝杆菌的生物活性
J Inorg Biochem. 2016 Sep;162:135-145. doi: 10.1016/j.jinorgbio.2016.06.023. Epub 2016 Jun 25.
10
The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.联吡啶和联吡啶二醇钌(II)芳烃配合物的化学性质对比及其对癌细胞的细胞毒性
Inorg Chem. 2008 Dec 15;47(24):11470-86. doi: 10.1021/ic801361m.

引用本文的文献

1
Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review.用于对抗病原微生物的钌配合物。全面综述。
Pharmaceutics. 2021 Jun 13;13(6):874. doi: 10.3390/pharmaceutics13060874.
2
Metal-Peptide Complexes as Promising Antibiotics to Fight Emerging Drug Resistance: New Perspectives in Tuberculosis.金属-肽复合物作为对抗新出现的耐药性的有前景的抗生素:结核病的新视角
Antibiotics (Basel). 2020 Jun 18;9(6):337. doi: 10.3390/antibiotics9060337.
3
A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by .
一种纳米结构脂质体系,用于提高钌(II)配合物的口服生物利用度,以治疗由……引起的感染。
Front Microbiol. 2018 Dec 6;9:2930. doi: 10.3389/fmicb.2018.02930. eCollection 2018.
4
Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in ?IQG-607是否是一种具有明确分子靶点的潜在金属药物或前体金属药物?
Front Microbiol. 2018 May 1;9:880. doi: 10.3389/fmicb.2018.00880. eCollection 2018.
5
Combatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity.对抗抗生素耐药性:光可活化钌(II)-异烟肼复合物展现出快速的选择性抗分枝杆菌活性。
Chem Sci. 2017 Jan 1;8(1):395-404. doi: 10.1039/c6sc03028a. Epub 2016 Aug 30.
6
Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against .用于掺入铜(II)配合物以对抗……的纳米结构脂质载体
Drug Des Devel Ther. 2017 Mar 20;11:909-921. doi: 10.2147/DDDT.S127048. eCollection 2017.
7
Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.中子活化可增强钌基配合物的活性,并在不依赖p53肿瘤抑制基因的情况下诱导胶质瘤细胞死亡。
Biometals. 2017 Apr;30(2):295-305. doi: 10.1007/s10534-017-0006-1. Epub 2017 Mar 3.
8
Antioxidant enzyme inhibitor role of phosphine metal complexes in lung and leukemia cell lines.磷化氢金属配合物在肺癌和白血病细胞系中的抗氧化酶抑制作用
Bioinorg Chem Appl. 2014;2014:717421. doi: 10.1155/2014/717421. Epub 2014 Dec 28.
9
Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cells.钌(II)氨基酸配合物对肉瘤-180肿瘤细胞的细胞毒性及凋亡机制
PLoS One. 2014 Oct 17;9(10):e105865. doi: 10.1371/journal.pone.0105865. eCollection 2014.
10
Nitro/nitrosyl-ruthenium complexes are potent and selective anti-Trypanosoma cruzi agents causing autophagy and necrotic parasite death.硝基/亚硝基钌配合物是强效且具有选择性的抗克氏锥虫药物,可导致自噬和寄生虫坏死性死亡。
Antimicrob Agents Chemother. 2014 Oct;58(10):6044-55. doi: 10.1128/AAC.02765-14. Epub 2014 Aug 4.